Life ScienceCompany
Who owns Admune Therapeutics?
Admune Therapeutics is owned by Novartis AG. It was acquired in 2015.
Admune Therapeutics is owned by Novartis AG. It was acquired in 2015.
107 Water Street,
Danvers, Massachusetts
01923
United States,
(888) 666-2560
www.admune.com
| Status | Dates | Investor(s) | |
|---|---|---|---|
| Investment | Exit | ||
| Current | 2015-10-21 | Novartis | |
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.